EXTON,
Pa., Jan. 6, 2025 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced that Cindy Reiss-Clark,
Sr. VP and Chief Commercial Officer; Chad
Winters, VP of Finance and Chief Accounting Officer; and
John Sweeney, VP of Investor
Relations, will present at the CJS 25th Annual "New
Ideas for the New Year" Virtual Investor Conference on January 14, 2025 at 10:15
a.m. ET.
A live audio webcast will be available via the Investors section
of our website, www.westpharma.com.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With 10,000
team members across 50 sites worldwide, West helps support our
customers by delivering approximately 43 billion components and
devices each year.
Headquartered in Exton,
Pennsylvania, West in its fiscal year 2023 generated
$2.95 billion in net sales. West is
traded on the New York Stock Exchange (NYSE: WST) and is included
in the Standard & Poor's 500 index. For more information, visit
www.westpharma.com.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or its
subsidiaries, in the United States and other jurisdictions, unless
otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-pharmaceutical-services-to-present-at-the-cjs-25th-annual-new-ideas-for-the-new-year-investor-conference-302343236.html
SOURCE West Pharmaceutical Services, Inc.
